DAShED

The DAShED (Diagnosis of Acute Aortic Syndrome in the ED) study: An observational cohort study of people attending the ED with symptoms consistent of Acute Aortic syndrome (AAS)

Acute aortic syndrome (AAS) is a life-threatening emergency condition affecting the upper aorta affecting ~4000 people in the UK a year with an ED misdiagnosis rate as high as 38%.

Previous research has identified several strategies combining clinical probability scoring with blood tests (D-Dimer) to rule out the condition but when applied to a large population (ED) with relatively low numbers of actual cases, these result in a high rate of computed tomographic angiography (CTA) scanning. Current guidelines reflect the uncertainty of existing evidence.

This study, the first phase of three (we are seeking funding from RCEM for phase 1 only) aims to describe the characteristics of ED attendances with possible AAS, to determine the service implications of using different diagnostic strategies and inform future research

We plan to recruit all ED attendances with possible AAS in at least 5 EDs over a 4-week period. We plan a prospective and retrospective approach to data collection adopting a zero-consent strategy with endpoint measures describing the characteristics of patients presenting with possible AAS.

We were delighted to learn in April 2022, that DAShED received funding from RCEM

Study draft paperwork

Draft protocol v1.1

Preliminary published work:

Scottish RCEM Conference: Acute aortic syndrome Clinician Survey abstract

Scottish RCEM Conference: Acute Aortic Syndrome (AAS) in NHS Lothian: a local retrospective case note review abstract

Scottish RCEM Conference: Acute Aortic Syndrome (AAS) in NHS Lothian: a local retrospective case note review slideshow

Scottish RCEM Conference 2022: Building a research case for better Acute Aortic Syndrome diagnosis slideshow; Matt Reed; RCEM Professor; Rachel McLatchie; ST5 EM trainee

 

Status: coming-soon

Start Date

June 2022

Chief Investigator

Dr Rachel McLatchie

Coordinated by

Nicky Freeman

Main Trial Site

Royal Infirmary of Edinburgh

End date

December 2022